Joe Rogan Experience #2548 - Brian Simpson · Aired Sep 1, 2026
Claim summary · not a verbatim quotation
During the AIDS crisis, patients were given AZT as a treatment, which killed them faster than the cancer was killing them.
The finding
What the evidence shows
This claim is not supported by the clinical evidence. In the original 1987 trial, patients getting AZT died at a much lower rate than those on placebo, and the trial was actually stopped early because placebo patients were dying so much faster that continuing was seen as unethical. AZT did cause serious side effects like anemia at the doses first used, but health experts and researchers have found no documented case of AZT killing a patient faster than the disease itself.
Read the supporting source · www.berkshireeagle.com ↗Quick answer & review status
Quick answer
Is it true that during the AIDS crisis, patients were given AZT as a treatment, which killed them faster than the cancer was killing them?
No, not as stated. This claim is not supported by the clinical evidence. In the original 1987 trial, patients getting AZT died at a much lower rate than those on placebo, and the trial was actually stopped early because placebo patients were dying so much faster that continuing was seen as unethical. Joe Rogan said it (matched by voice) on Joe Rogan Experience #2548 - Brian Simpson, aired Sep 1, 2026, at 18:09. The supporting source is berkshireeagle.com, linked below.
The context belongs here.
No separately verified on-air correction is recorded for this check. That is not a claim that nobody corrected it.
- Attribution
- Not independently confirmed in this record
- Editorial context review
- Not recorded; generated finding
- Coverage
- One selected claim from the episode
Revisions to this check
No dated revision is recorded here. Older checks may predate this log.
Challenge this finding or add context →Keep the evidence coming.
Follow new checks in your RSS reader, or catch up with the weekly briefing on the site.
Email signup is currently unavailable.
Prefer to catch up here? Read the weekly briefing.